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Summary
Increasing evidence suggests functional compart-
mentalization of interphase nuclei [1]. This includes
preferential interior localization of gene-rich and early
replicating chromosome regions versus peripheral
localization of gene-poor and late replicating chromo-
some regions [2, 3], association of some active genes
with nuclear speckles [4, 5] or transcription ‘‘factories’’
[6], and association of transcriptionally repressed
genes with heterochromatic regions [7]. Dynamic
changes in chromosome compartmentalization [7–9]
imply mechanisms for long-range interphase chroma-
tin movements. However, live cell imaging in mamma-
lian cells has revealed limited chromatin mobility [10],
described as ‘‘constrained diffusion’’ [11]. None of
these studies, though, have examined a chromosome
locus undergoing an inducible repositioning between
two different nuclear compartments. Here we demon-
strate migration of an interphase chromosome site
from the nuclear periphery to the interior 1–2 hr after
targeting a transcriptional activator to this site. Spot
redistribution is perturbed by specific actin or nuclear
myosin I mutants. Extended periods of chromosome
immobility are interspersed with several minute pe-
riods in which chromosomes move unidirectionally
along curvilinear paths oriented roughly perpen-
dicular to the nuclear envelope at velocities of 0.1–
0.9 mm/min over distances of 1–5 mm. Our results
suggest an active mechanism for fast and directed
long-range interphase chromosome movements de-
pendent directly or indirectly on actin/myosin.
Results and Discussion
Previously, we described a simplified system in which
tethering the transcription acidic activation domain
(AAD) of the viral protein VP16 to a peripheral chromo-
somal site in CHO DG44 C6 cells led to its repositioning
toward the nuclear interior [12]. To visualize the dynam-
ics of this repositioning, we created an inducible VP16
AAD targeting system by using rapamycin-induced
*Correspondence: asbel@uiuc.edu
3 Present address: Whitehead Institute for Biomedical Research,
9 Cambridge Center, Cambridge, Massachusetts 02142.heterodimerization of the protein FKBP12 to the protein
domain FRB* from the protein FRAP [13, 14] (Figure 1A).
The C6 cell line contains a 10–20 copy transgene inser-
tion of a plasmid containing a 256 copy lac operator
direct repeat and a DHFR cDNA selectable marker
[12]. In C6C8C12 cells, a C6 cell line derivative stably
expressing EGFP-lac repressor- (FKBP12)3 and FRB*-
VP16 AAD, rapamycin addition induces heterodimeriza-
tion within the first several minutes, reaching steady
state by 15 min [15]. Northern blot analysis reveals
increased DHFR transgene transcripts within 60 min,
with stable transcript levels reachedw90 min after add-
ing rapamycin (data not shown).
The C6 vector integration site shows a highly prefer-
ential localization close to the nuclear periphery. Target-
ing VP16 AAD in log phase cells resulted in a maximum
change in intranuclear distribution 1–2 hr after rapamy-
cin addition, with a slight but characteristic rebound
toward steady-state levels by 3 hr (Figure 1B). The ob-
served movement of spots toward the nuclear interior
is significant at greater than a 99% confidence level
based on a 0.03–0.04 estimated standard deviation of
the mean proportion of peripherally associated spots.
A nearly identical time course for spot repositioning
was obtained for cells blocked in late G1/early S phase
by hydroxyurea (HU) (Figure 1C), suggesting similar
and efficient chromosome repositioning throughout a
large fraction of the cell cycle.
Previously, we showed that targeting VP16 AAD to
a gene-amplified, heterochromatic chromosome region
resulted in dramatic decondensation of large-scale
chromatin structure [16]. More recently, we showed
that most acidic activators tested, including activation
domains from Gal4, p53, and p65, a component of
NF-KB, induced comparable chromatin unfolding [15].
Similarly, the capability of inducing spot redistribution
is likely to be a general property of acidic activators,
as targeting the mammalian p65 activation domain in-
duced comparable spot migration to the nuclear interior,
with nearly identical kinetics, as that seen with the viral
VP16 AAD (Figure 1D and data not shown).
Targeting a synthetic acidic peptide, which decon-
denses large-scale chromatin structure similarly to
VP16 but does not activate transcription [15], also in-
duced spot repositioning (Figure 1E). Moreover, inhibit-
ing transcription with DRB had no effect on chromosome
repositioning (Figure 1F), while chromosome reposition-
ing after inhibiting transcription with a-amanitin was
delayed by w1 hr (data not shown). We conclude that
transcription is not required for long-range movement.
Initial live cell imaging revealed a surprisingly strong
photosensitivity of long-range motion to near UV and
blue light (Figure 1G, see Figure S1 in the Supplemental
Data available with this article online). Control experi-
ments enabled us to identify illumination conditions
that produced spot redistribution statistics similar to
that observed in cells never exposed to light (Figure 1H,
Supplemental Data).
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826Figure 1. VP16 Induces Chromosome Repo-
sitioning from Nuclear Periphery to Interior
(A) EGFP-lac repressor protein with three
copies of FKBP12 binds nonfluorescent
FRB*-VP16 after rapamycin addition.
(B) Percentage of log phase cells with tagged
chromosome spot less than 0.5 mm from
nuclear periphery at different times after ra-
pamycin addition (bars represent standard
deviation of the mean based on three experi-
ments).
(C–H) Percentage of peripheral (black) versus
interior (gray) sites.
(C) Similar redistribution of chromosome site
2 hr after VP16 targeting in cells blocked in
late G1/early S.
(D) The acidic activation domain from p65, an
endogenous protein, produces similar spot
redistribution as seen for the VP16 AAD after
targeting induced by rapamycin addition.
(E) Redistribution toward cell interior occurs
after targeting an acidic peptide capable of
decondensing large-scale chromatin struc-
ture but with no transcriptional activity.
(F) Redistribution of chromosome site after
transcription inhibition by DRB.
(G and H) Spot redistribution 2 hr after adding
rapamycin is dependent on illumination con-
ditions. Data points are from 100–200 cells
(C–H) or 300 cells (B).Under these conditions, live cell imaging confirmed
significant long-range chromosome movement induced
by VP16 targeting (Figure 2A). Changes in spot distance
from the nuclear periphery up tow2.5 mm in magnitude
were observed between 0 and 2 hr after VP16 targeting
(Figure 2B, black diamonds), with an average displace-
ment of 1.1 mm and a pronounced bias for movement
of spots near the periphery (%1.5 mm) toward the nu-
clear interior (positive y values, Figure 2B). Significantly,
chromosome displacements between 0 and 2 hr in nearly
all cells with targeted VP16 exceeded the largest dis-
placements observed in all three controls (Figure 2B,
Figure S2). These controls included the parental C6C8
cells, stably expressing EGFP-lac repressor- (FKBP12)3
but not FRB*-VP16 AAD, to which rapamycin was added
(Figure 2B, open circles). Therefore, the observed
changes in spot position cannot be attributed to general
changes in nuclear and/or chromatin structure induced
by rapamycin. They also included C6C8C12 cells to
which no rapamycin was added (Figure S2B) and 610
cells containing an interior located spot of comparable
size to that in C6 cells (Figure S2C).
Our next goal was to observe the general pattern of
movement after VP16 targeting. We divided the 400 min-
imal exposures permissible without incurring phototox-
icity (Figure 1H) by taking 3D data (20 optical sections,
0.075 mm focus step) every 6 min between 0 and 2 hr,
during which time 12/15 rapamycin-treated cells, versus
0/15 control cells, showed a spot movement exceeding1 mm. These data revealed long periods of localized
movements punctuated by shorter periods of abrupt,
long-range movements, often occurring within only 1–2
6 min intervals (Figure S3 and Supplemental Data). Plot-
ting the mean distance change between adjacent time
points as a function of time suggested a mobility peak
at w1 hr after rapamycin addition (data not shown), in
agreement with the maximum observed drop in periph-
eral spot percentage between 1 and 1.5 hr, as measured
in fixed cells (data not shown). However, in individual
cells, long-range motions could occur before or after
this 1 hr time point.
To determine the actual spot trajectories during these
short periods of rapid motion, we next collected 3D data
(20 optical sections, 0.075 mm focus step) every minute
for 20 min. To maximize the percentage of cells ob-
served undergoing long-range motion, we therefore be-
gan observations during this period of peak mobility
starting 1 hr after adding rapamycin. Approximately
1/3 of cells (14/43) during these 20 min showed long-
range chromosome spot movements exceeding 1 mm
(Figures 2C–2E), as determined by plots of radial
spot distance from the nuclear periphery versus time.
(Predictably, this is a lower percentage than observed
over the entire 2 hr time period via 6 min data sampling.)
To better visualize spot trajectories, we created video
images by assembling the most in-focus optical sec-
tion per time point. Focal changes were minimal during
these rapid, long-range movements (Figures 2C–2E).
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Range Spot Movements
(A) Chromosome site (arrowheads) has
moved toward nuclear interior 2 hr after rapa-
mycin addition.
(B) Scatter plot showing net radial movement
of spots between 0 and 2 hr after rapamycin
addition in cells expressing FRB*-VP16 (black
diamonds) or control cells not expressing
FRB*-VP16 (open circles). x axis is starting
distance from nuclear periphery, y axis is net
radial distance moved toward (positive) or
away (negative) from nuclear interior.
(C) Spot undergoing long-range motion: num-
bers show time in minutes after rapamycin
addition followed by optical section number
(out of 21) from z-stack (0.075 mm focus
step). Movement occurs roughly perpendicu-
lar to nuclear envelope. See also Movie S1.
(D) Spot movement occurs without signifi-
cant change in focus or nuclear shape during
period of rapid motion. Optical sections
w0.75 mm below (top) or above (bottom)
spot focus (middle) are shown from this pe-
riod of rapid spot movement. (Upper right,
optical section number, 0.075 mm focus
step; middle row, panel lower left, time in
minutes after rapamycin addition.) See also
Movies S1 and S3.
(E) Second example showing spot move-
ment, with minimal changes in focus, from
periphery toward the nuclear interior. Num-
bers shown are as in (C). Scale bars equal
5 mm.Strikingly, nearly all (12/14) of these video images ap-
peared to show the spots following curvilinear trajecto-
ries (Movies S1–S6). The two exceptions were inconclu-
sive due to significant nuclear shape changes during
the motion.
To objectively analyze spot trajectories and minimize
effects from changes in nuclear position, rotation, or
size, a single, in-focus image from each time point was
aligned in 2D by a crosscorrelation approach with the
image from the preceding time point. Individual 2D im-
ages from different time points were projected into a sin-
gle 2D image to show the 2D spot trajectory (Figure 3).
These projected trajectories confirmed a striking linear-
ity to the VP16-induced rapid movements in all cases
(10/10) where minimal nuclear shape changes allowed
reasonable alignment (Figures 3D–3M). Trajectory
lengths varied from 1.3 to 5.2 mm (mean 2.6 mm).
Equally striking was the pronounced trajectory radial
bias. 5/10 trajectories were oriented 90º 6 10º with re-
spect to the nuclear periphery, and 9/10 were oriented
90º 6 45º. Assuming random angular distribution be-
tween 0º and 180º, the binomial distribution probabilities
for R5/10 and 9/10 trajectories with these orientations
is <.003 and .01, respectively. All aligned trajectories
(10/10) and 11/12 total trajectories moved initially to-
ward the nuclear interior (p < .001 or .005, respectively),
with just 1 trajectory oriented toward the periphery.Nuclear rotation has been observed in neuronal and
other cells with round nuclei [17], raising the question
of whether the observed curvilinear motion could be
explained by a similar nuclear rotation. Previous work
combining nuclear pore staining with optical sectioning
demonstrated that the movement of the C6 spot in re-
sponse to a direct lac repressor-VP16 fusion protein
was due to true redistribution of peripheral spots to
the nuclear interior [12], and this has been confirmed
by the FRB-FBP12-inducible VP16 targeting system in
C6C8C12 cells (Figure S5). Moreover, examination of
the 2D and 3D image data clearly rules out nuclear
rotation as a general explanation for the observed
trajectories.
First, the majority of projected trajectory examples
shown in Figures 3F–3H and 3J–3M have asymmetries
in the trajectory and/or nuclear shape (together with
the overall flattened, elliptical nuclear profile, which
shows no changes during the motion), which are incon-
sistent with nuclear rigid-body rotations. One might
imagine that compression by the cytoskeleton might
lead to a simultaneous nuclear rotation and shape defor-
mation to maintain the flattened nuclear profile. How-
ever, it is hard to imagine how a nucleus would simulta-
neously rotate and deform such that no change in
nuclear shape was observed for a spot motion that
would have to be explained by an off-axis nuclear
Current Biology
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Show Curvilinear Trajectories
From each time point, the single optical sec-
tion for which the spot was in focus was ex-
tracted from the 3D data stack. A crosscorre-
lation approach was used to align these 2D
images from adjacent time points to correct
for nuclear translation and rotation and small
changes in nuclear shape, forming an image
stack where each section now corresponds
to a different time point. This image stack
was then projected to yield the spot trajec-
tory over time.
(A) Linear trajectory (600–670) is followed by
longer period of localized, short-range mo-
tion (680–800). Time refers to minutes after ra-
pamycin addition. See also Movie S1.
(B and C) Trajectories of a cell not showing
long-range motion after rapamycin addition
(B) and a control cell (no rapamycin) (C) show-
ing limited, apparently random movements
confined within small region. The radius of
confinement appears smaller for the control
cells versus cells exposed to rapamycin that
did not show long-range spot movements
(see also Figure 4). See also Movies S5 and
S6.
(D–M) Trajectories from cells showing long-
range spot movements.
(G) See also Movie S3.
(H) See also Movie S4.
(E) Corresponds to 600–640 (see Movie S2), all
the rest are 600–790. Scale bars equal 5 mm.rotation. Moreover, spots near the edge of the nucleus
still would show significant changes in focus during
such combined nuclear rotations and deformations as
the conveyer belt-like motion of the nuclear envelope
carried the spot from the side of the nucleus to its top
or bottom. In fact, measurement of the spot z-position
by the optical section stacks from each time point shows
variations of only a few tenths of a micron (Figures 2C–
2E), relative to an estimated nuclear height ofw3–5 mi-
crons, during the period of rapid motion for most of the
trajectory examples (5/6 plotted in Figure 4B).
In general, distinguishing nonrandom directed motion
from free or constrained diffusion is quite difficult in sit-
uations in which both types of motion occur. Even in
cases of pure diffusion, a small subset of trajectories
will appear linear. However, this is not the case here.
Spot trajectories instead appear to fall into two, distinct
categories: curvilinear, long-range movements (Figures
3A and 3D–3M) versus constrained motion within a small
radius. The latter category was typical of the 29/43 cells
in which long-range motion was not observed (Figures
3B and 4C) and all control cells (30), which in general ap-
pear to show constrained motion within an even smaller
radius (Figures 3C and 4D). Within individual trajecto-
ries, short periods of rapid, curvilinear long-range mo-
tion (Figure 3A, top) are flanked by constrained motion
within a small radius (Figure 3A, bottom). In a few cases,
spots follow a linear trajectory, pause for what appears
to be small constrained diffusion movements, thenresume linear long-range movement at a different angle
(Figure S4). During these periods of rapid, directional
motion, roughly constant radial velocities (0.14–0.85
mm/min, mean 0.31 mm/min) are observed (Figure 4A).
These velocities approach the w1 mm/min measured
for anaphase chromosome movements. No examples
of long-range spot movement were observed in 30 con-
trol cells not treated with rapamycin, as determined by
the plots of radial distance versus time (Figure 4D).
This conclusion of two distinct motion states is sup-
ported by a commonly used statistical method for ana-
lyzing particle motion by means of the dependence of
mean square distance (MSD) with time [18]. Control cells
show an initial linearity for spot movements followed by
a plateau (Figures 4E and 4F, green), consistent with
constrained diffusion models [19]. After VP16 targeting,
two cell subpopulations emerge with qualitatively differ-
ent MSD plots. 29 cells, whose spots do not undergo
long-range motion, show a similar constrained diffusion
MSD pattern, with increases in diffusion and constraint
radii values just a few times larger (Figures 4E and 4F,
orange). Differences in MSD plots between these and
control cells parallel those previously observed for chro-
mosome regions in mammalian cells associated or not
associated with the nuclear periphery or nucleoli [10].
In contrast, cells undergoing long-range motion pro-
duce a qualitatively different MSD plot (Figure 4E, red,
blue). MSD values are w50-fold higher than in control
cells. Moreover, MSD values continue to increase with
Directional Movement of Interphase Chromosomes
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Regimes—Rapid,Long-RangeMobility IsDis-
tinct from Short-Range, Localized Mobility
(A) Distance from nuclear periphery versus
time—during short periods of rapid, long-
range motion, roughly constant velocities
(i.e., linear plots) are observed. Red plot cor-
responds to cell shown in Figures 2C, 2D,
3A, and 3D orange plot corresponds to cell
shown in Figures 2E and 3G. See also Movies
S1–S4.
(B) Relative changes in focus for same cells
shown in (A).
(C) Distance from nuclear periphery versus
time for spots from cells treated with rapamy-
cin but not showing long-range movements.
Fluctuations in distance from nuclear enve-
lope appear several times larger than ob-
served in control cells (no rapamycin), which
show only small position fluctuations and no
persistent, unidirectional, long-range move-
ments (D).
(E and F) Mean square distance from periph-
ery versus time lag shows qualitative differ-
ences in mobility. (E) Averages from 14 trajec-
tories showing long-range motion (blue),
including 10 curvilinear trajectories from
aligned data sets (red), versus 29 spot trajec-
tories (orange in [E] and [F]), which did not
show long-range motion after rapamycin ad-
dition, and 30 control trajectories (green in
[E] and [F]).a noticeable concave shape, consistent with ‘‘free
diffusion’’ superimposed on ‘‘velocity flow’’ or directed
motion [19].
We next began to address the molecular basis of this
spot long-range movement. Actin [20] and an isoform
of myosin IC [21] have been identified in the nucleus.
Immunofluorescence microscopy demonstrated the
recruitment of this nuclear myosin I (NMI) by VP16 to a
large, gene-amplified chromosome array (Figure 5A).
Colocalization is partial but significant, covering a large
extent of the GFP signal. Spot redistribution after VP16
targeting was delayed several hours after transient
transfection of a mutant NLS-tagged NMI (E407V) (Fig-
ure 5B), with the change in percentage of peripheral
spots not becoming statistically significant at greater
than the 99% confidence level until 5 hr after rapamycin
addition, versus 2 hr for the control. The corresponding
mutation (E470A) in the smooth muscle myosin II heavy
chain locks myosin II into a weak actin binding state,
blocking in vitro actin filament motility [22]. Normal
spot redistribution was observed after transfection
with the NLS-tagged myopathy loop deletion NMI mu-
tant (Figure 5C). The myopathy loop is in a putative actin
binding site; myopathy loop deletions in myosin II still
exhibit motor activities, although at lower levels [23].
Spot redistribution was blocked by BDM (2-3-Butane-
dione monoxime) (Figure 5D). Although BDM has been
widely used as a nonmuscle myosin inhibitor, recent
work has shown no inhibition for several nonmusclemyosins but rather inhibition of actin dynamics [24].
Transient expression of mRFP-actin-NLS had no effect
on spot redistribution kinetics (Figure 5F, gray bars).
Transfected cells were identified based on their nuclear
mRFP fluorescence, with nontransfected cells on the
same coverslips serving as controls. However, expres-
sion of a similarly tagged, nonpolymerizable mutant ac-
tin (G13R) [25] completely blocked spot redistribution
after VP16 targeting (Figure 5E). In distinct contrast,
a tagged, mutant actin (S14C), which stabilizes F-actin
[26], instead shifted the spot redistribution toward
earlier times (Figure 5F). The characteristic minimum in
peripherally located spots shifted from 2 to 1.5 hr after
rapamycin addition, with the percentage of peripheral
spots first becoming statistically significantly lower at
greater than the 99% confidence level at 1 hr after rapa-
mycin addition versus 1.5 hr for the wild-type actin con-
trol. Moreover, the percentage of peripheral spots for
the wild-type actin control versus the S14C mutant at 1
hr after rapamycin addition are different at a 99% confi-
dence level, while the wild-type value at 1.5 hr after rapa-
mycin addition is identical to the S14C value at 1 hr after
rapamcyin addition at greater than a 99% confidence
level. From this we conclude that expression and nu-
clear targeting of the F-actin stabilizing actin construct
causes an acceleration of w0.5 hr in the rapamycin-
induced spot redistribution to the nuclear interior.
Our results reveal for the first time an active and
physiologically regulated translocation mechanism for
Current Biology
830Figure 5. Functional Analysis of Actin and Myosin in Spot Migration
(A) Recruitment of nuclear myosin I (red) to A03 amplified chromosome region (homogeneous staining region, HSR) containing lac operator sites
(arrows) after expression of EGFP-lac repressor-VP16 AAD (green). No recruitment was seen after expression of EGFP-lac repressor (green).
Scale bar equals 5 mm.
(B–F) Percentage of cells with peripheral chromosome location (averages from two [B–E] or three [F] experiments, 100 cells each).
(B) 3 hr delay in spot redistribution in cells expressing E407 NMI relative to control, nontransfected cells.
(C) No delay in cells expressing NMI with myopathy loop deletion.
(D) BDM blocks spot redistribution.
(E) Expression of mRFP-NLS-G13R mutant actin defective in polymerization blocks spot movement at all times.
(F) S14C actin mutant, favoring F-actin polymerization, accelerates spot redistribution (black) relative to wild-type actin (gray).long-range, directed interphase chromosome move-
ments. We suggest previous failures to observe long-
range interphase chromosome movements in mamma-
lian cells by live cell imaging were likely due to two
reasons. First, the default for interphase chromatin in
mammalian cells appears to be constrained diffusion
with chromatin mobility confined to small regions
[10, 11]. This implies that long-range chromatin move-
ments are under tight physiological regulatory control,
with only specific chromosome regions undergoing long-
range motion, and only under special circumstances and
for short time periods. Second, this motion appears to be
unusually photosensitive and blocked by even short ex-
posures with conventional microscope configurations.
Our findings provoke a number of fundamental, cell
biological questions. What are the molecular mech-
anism and possible motors for directed interphase chro-
mosome movements? We demonstrated long-range
chromatin movement dependent on actin and nuclear
myosin. The exact molecular mechanism underlying
this dependence—whether it is direct or indirect—
remains unknown. However, the elimination of spot re-
distribution by an actin point mutation defective in actin
polymerization and the accelerated spot redistribution
with an actin mutant that favors F-actin formation raises
the tantalizing possibility that the mechanism for long-
range chromatin movement directly involves F-actin and
myosin. Previously, we demonstrated that the lac oper-
ator-tagged spot in C6 cells also shows a cell cycle-
dependent motion during early S phase into the nuclear
interior in the absence of any targeted transcription
factor [12]. Experiments now in progress (C.-H.C. andA.S.B., unpublished data) indicate that this cell cycle-re-
lated motion is also blocked by BDM addition, suggest-
ing that long-range chromosome movements depen-
dent on actin/myosin may be a more general
phenomenon not restricted to our current transcription
factor-induced model for chromosome movement.
We can envision two alternative scenarios for such
a direct, active involvement. First, actin/myosin could
be required to actively target the spot to the nuclear pe-
riphery, requiring stretching of the flanking interphase
chromosome regions anchored distally to interior struc-
tures. Release of the spot attachment to the nuclear pe-
riphery would then lead to an elastic ‘‘recoil’’ with rapid
motion into the interior. We consider this model unlikely.
It does not explain examples in which the spot moves in
one direction, stops, then moves at a different angle. It
appears inconsistent with the observed near constant
velocity during periods of rapid motion. It is also incon-
sistent with our data showing a higher local mobility of
the spot after VP16 targeting, in cells in which long-
range motion is not occurring, as if the spot is no longer
firmly anchored to the nuclear periphery. Finally, this
model predicts that the percentage of spots localized
to the periphery in the absence of rapamycin might be
expected to decrease after expression of actin and
myosin mutants. The alternative scenario is that the
inward spot movement after transcription factor target-
ing directly involves actin/myosin.
Independent of the mechanism for active movement
per se, additional questions include what provides
directionality to this movement? What establishes the
apparent radial polarity within the nucleus? What is the
Directional Movement of Interphase Chromosomes
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transcriptional and/or epigenetic reprogamming?
Future work will exploit our simplified, engineered
system to begin to address these questions.
Supplemental Data
Supplemental Data include five figures, six movies, and Supple-
mental Experimental Procedures and can be found with this article
online at http://www.current-biology.com/cgi/content/full/16/8/
825/DC1/.
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